Bexacat™ (bexagliflozin tablets) is an SGLT2 inhibitor and the first FDA-approved oral treatment for feline diabetes in otherwise healthy, newly diagnosed cats.
Categories
October Surprise 2016 - octobersurprise2016.orgOctober Surprise 2016 - octobersurprise2016.org - - The News And Times